Clinical trial
Noninvasive Magnetocardiography Using the CardioFlux (TM) System in the Evaluation of Acute Coronary Syndrome Patients Going for Cardiac Catheterization
NCT04044391 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Noninvasive Magnetocardiography Using the CardioFlux (TM) System in the Evaluation of Acute Coronary Syndrome Patients Going for Cardiac Catheterization
- Lead sponsor
- Genetesis Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- May 15, 2019
- Completion date
- May 4, 2020
- Enrollment
- 101 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndrome, coronary artery stenosis, myocardial ischemia